All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
| SPY / SPDR S&P 500 ETF Put
|
|
|
|
|
|
|
|
| IART / Integra LifeSciences Holdings Corporation
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc. Call
|
|
|
|
|
|
|
|
| TNDM / Tandem Diabetes Care, Inc.
|
|
|
|
|
|
|
|
| TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
| MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
| MYGN / Myriad Genetics, Inc. Call
|
|
|
|
|
|
|
|
| OPNT / Opiant Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| OSMT / Osmotica Pharmaceuticals Plc
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| NVLN / NOVELION THERAPEUTICS INC.
|
|
|
|
|
|
|
|
| DOVA / Dova Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| LIVN / LivaNova PLC
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| VRAY / ViewRay Inc.
|
|
|
|
|
|
|
|
| XENT / Intersect ENT Inc
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
| REPH / Societal CDMO Inc
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| US64052L1061 / Neos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ADMS / Adamas Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
| PETX / Aratana Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| SLGL / Sol-Gel Technologies Ltd.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc. Call
|
|
|
|
|
|
|
|
| ADMA / ADMA Biologics, Inc.
|
|
|
|
|
|
|
|
| MTNB / Matinas BioPharma Holdings, Inc.
|
|
|
|
|
|
|
|
| SSKN / STRATA Skin Sciences, Inc.
|
|
|
|
|
|
|
|
| IDRA / Idera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
| XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
|
|
|
|
|
|
|
|
| TLGT / Teligent Inc
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
| BDSI / Biodelivery Sciences International
|
|
|
|
|
|
|
|
| NVRO / Nevro Corp. Call
|
|
|
|
|
|
|
|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
